Lobbying client · LD-2 disclosures
Amphastar Pharmaceuticals Inc.
California
33 filings from 4 registrants · 2008–2017 · latest filed Nov 2, 2017
Reported on its behalf
$1.3M
every LD-2 on file
Its own filed spend
$0
lobbying for itself
Fees to outside firms
$1.3M
across every firm on file
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Health Issues
HCR
18 filings
$450K on those filings
Pharmacy
PHA
5 filings
$470K on those filings
Medical/Disease Research/Clinical Labs
Who did the lobbying
Every lobbyist named on this client's filings.
- Bart Stupak Venable LLPCovered position: U.S. Representative, 1993-201123 filingsthrough 2017
- Gregory J Newell International Commerce Development Corp5 filingsthrough 2009
- Michelle Thurber Czapski Dickinson Wright PLLCCovered position: Attorney / Lobbyist1 filingthrough 2010
Covered positions · 2 of 3 lobbyists named on these filings disclosed a prior government post. The text is reproduced exactly as filed.
The filings
The 20 most recent of 33 filings. Every figure above is built from these records.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: amphastar-pharmaceuticals-inc.